Novartis Sued Over 'Virus Production' Patent For Flu Shots

Law360, New York (January 6, 2014, 8:17 PM EST) -- A Novartis AG unit ripped off a Canadian company's patented process for increasing virus production and using it to make a flu vaccine, according to a suit filed in Texas federal court Monday.

Microbix Biosystems Inc. alleges that Switzerland-based Novartis Vaccines and Diagnostics Inc. misappropriated Microbix's methodology for upping virus yields during the manufacturing of vaccines and unlawfully relied on it to produce Novartis' Agriflu.

“VirusMax is a novel technology that was developed by our company at significant cost," Vaughn Embro-Pantalony, president and CEO of Microbix,...
To view the full article, register now.